Wednesday, July 22, 2026 The SC.28 SEAMLESS Study: A Pragmatic Multi-Site Randomized Waitlist-Controlled Trial of a Smartphone App-Based Mindfulness Intervention for French and English Speaker Cancer Survivors has closed to accrual with 300 participants randomized to the study. The purpose of this study is to test if a mindfulness program (Mindfulness Based Cancer Survivorship (MBCS) Journey) delivered through a mobile Am Mindfulness smartphone application can reduce ongoing psychosocial symptoms such as stress, anxiety, depression, fatigue, and fear of cancer recurrence or progression that are often experienced by survivors. The study involves using the app daily for four weeks and can be done totally remotely from one's own home, anywhere in CanadaFor more information:SC28 members trial pageSC28 NCT05470010 on www.clinicaltrials.gov
